Promoting Mother-Baby Bonding Through a Relaxation Routine During Pregnancy
1 other identifier
interventional
106
1 country
1
Brief Summary
The aims of this study are to determine if:
- 1.during pregnancy, a progressive muscle relaxation and abdominal touch ritual involving a pleasing scent (i.e. a "relaxation ritual") can, acutely, reduce maternal stress and affect the fetus (in terms of movement, changes in heart rate and heart rate variability);
- 2.a progressive muscle relaxation and abdominal touch ritual involving a pleasing scent (i.e. a "relaxation ritual") during pregnancy can have an effect on mitochondria functioning in the placenta through reducing maternal stress during pregnancy (based on our recent findings (Monk et al, 2016));
- 3.the scent will come to function as a conditioned stimulus such that exposure to the scent postpartum will induce greater maternal relaxation, which will have an effect on the mother-infant interaction and infant physiology;
- 4.prenatal maternal exposure to scent combined with abdominal touch will lead to mothers' increased likelihood of utilizing infant massage with a lotion of the same scent postpartum;
- 5.the prenatal ritual and the increased likelihood of engaging in infant massage will lead to a maternal perception of greater mother-infant bonding, attachment and parenting efficacy, and improved maternal mood;
- 6.the prenatal ritual and the increased likelihood of engaging in infant massage will lead to improved performance on the conjugate reinforcement paradigm conditioning task administered to infants at 4 months of age
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 13, 2016
CompletedFirst Posted
Study publicly available on registry
October 24, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedAugust 1, 2023
July 1, 2023
6.7 years
October 13, 2016
July 29, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Mother-Infant Bonding assessed by Postpartum Bonding Questionnaire
Improved level of mother-infant bonding as assessed by Postpartum Bonding Questionnaire
6 weeks to 4 months postpartum
Secondary Outcomes (1)
Change in Maternal Stress Level during Pregnancy as assessed by Perceived Stress Scale
Change over time from 24 weeks gestation to 36 weeks gestation
Study Arms (4)
Coached Intervention
EXPERIMENTALPerform prenatal relaxation exercise in the lab with a coach and at home
Home Intervention
ACTIVE COMPARATOROnly perform relaxation exercise at home
Control Group
NO INTERVENTIONNever performs relaxation routine, attends prenatal assessment sessions
Postpartum Only
NO INTERVENTIONOnly attends visits postpartum, never receives prenatal assessments
Interventions
Groups receiving the intervention will be asked to engage in the relaxation protocol every day. Participants will be asked to continue practicing the relaxation protocol for the remainder of their pregnancy. Participants will be instructed to listen to the 7 minute guided muscle relaxation tape and engage in the 3 minute abdominal touch routine in the presence of the scent stick. Participants will be provided with a scent stick of their selected scent to take home. For the duration of the study, participants will be loaned standard headphones and an iPod Touch that contains only the guided progressive muscle relaxation audio recording to facilitate this at-home protocol.
Eligibility Criteria
You may qualify if:
- Pregnant women between 18-45 years old,Self-report
- Not smoking during pregnancy,Self-report
- Healthy pregnancy,Self-report
- weeks ± 3 weeks gestation by time of enrollment,Self-report
- Delivering baby at CUMC- CHONY or Allen Pavilion,Self-report
- Receiving prenatal care,Self-report
You may not qualify if:
- Multi-fetal pregnancy, Selfreport
- Taking medications that affect the cardiovascular system (α blockers, β blockers, corticosteroids, chronic-use asthma medications (e.g. beta2-adrenoceptor agonists), Selfreport
- Drinking alcohol or using recreational drugs during pregnancy, Selfreport
- Premature birth (before 37.5 weeks gestation)\*, Medical record
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- New York State Psychiatric Institutelead
- Johnson & Johnsoncollaborator
Study Sites (1)
Columbia University Medical Center
New York, New York, 10032, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Catherine Monk, Ph.D.
Columbia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Behavioral Medicine (in Psychiatry) at CUMC
Study Record Dates
First Submitted
October 13, 2016
First Posted
October 24, 2016
Study Start
October 1, 2016
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
August 1, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share